111 related articles for article (PubMed ID: 38873612)
1. Oropharyngeal microbial ecosystem perturbations influence the risk for acute respiratory infections in common variable immunodeficiency.
Pulvirenti F; Giufrè M; Pentimalli TM; Camilli R; Milito C; Villa A; Sculco E; Cerquetti M; Pantosti A; Quinti I
Front Immunol; 2024; 15():1371118. PubMed ID: 38873612
[TBL] [Abstract][Full Text] [Related]
2. Bacterial but Not Fungal Gut Microbiota Alterations Are Associated With Common Variable Immunodeficiency (CVID) Phenotype.
Fiedorová K; Radvanský M; Bosák J; Grombiříková H; Němcová E; Králíčková P; Černochová M; Kotásková I; Lexa M; Litzman J; Šmajs D; Freiberger T
Front Immunol; 2019; 10():1914. PubMed ID: 31456808
[TBL] [Abstract][Full Text] [Related]
3. Upper Respiratory Dysbiosis with a Facultative-dominated Ecotype in Advanced Lung Disease and Dynamic Change after Lung Transplant.
Simon-Soro A; Sohn MB; McGinniss JE; Imai I; Brown MC; Knecht VR; Bailey A; Clarke EL; Cantu E; Li H; Bittinger K; Diamond JM; Christie JD; Bushman FD; Collman RG
Ann Am Thorac Soc; 2019 Nov; 16(11):1383-1391. PubMed ID: 31415219
[No Abstract] [Full Text] [Related]
4. Fecal Immunoglobulin Levels as a Modifier of the Gut Microbiome in Patients with Common Variable Immunodeficiency.
Nöltner C; Bulashevska A; Hübscher K; Haberstroh H; Grimbacher B; Proietti M
J Clin Immunol; 2023 Aug; 43(6):1208-1220. PubMed ID: 36961604
[TBL] [Abstract][Full Text] [Related]
5. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
[TBL] [Abstract][Full Text] [Related]
6. Patients With Common Variable Immunodeficiency (CVID) Show Higher Gut Bacterial Diversity and Levels of Low-Abundance Genes Than the Healthy Housemates.
Bosák J; Lexa M; Fiedorová K; Gadara DC; Micenková L; Spacil Z; Litzman J; Freiberger T; Šmajs D
Front Immunol; 2021; 12():671239. PubMed ID: 34054845
[TBL] [Abstract][Full Text] [Related]
7. Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation.
Jørgensen SF; Trøseid M; Kummen M; Anmarkrud JA; Michelsen AE; Osnes LT; Holm K; Høivik ML; Rashidi A; Dahl CP; Vesterhus M; Halvorsen B; Mollnes TE; Berge RK; Moum B; Lundin KE; Fevang B; Ueland T; Karlsen TH; Aukrust P; Hov JR
Mucosal Immunol; 2016 Nov; 9(6):1455-1465. PubMed ID: 26982597
[TBL] [Abstract][Full Text] [Related]
8. Dysimmunity in common variable immunodeficiency is associated with alterations in oral, respiratory, and intestinal microbiota.
Cabanero-Navalon MD; Garcia-Bustos V; Mira A; Moral Moral P; Salavert-Lleti M; Forner Giner MJ; Núñez Beltrán M; Todolí Parra J; Bracke C; Carda-Diéguez M
Clin Immunol; 2023 Nov; 256():109796. PubMed ID: 37774905
[TBL] [Abstract][Full Text] [Related]
9. Chronic cigarette smoke exposure and pneumococcal infection induce oropharyngeal microbiota dysbiosis and contribute to long-lasting lung damage in mice.
Hilty M; Wüthrich TM; Godel A; Adelfio R; Aebi S; Burgener SS; Illgen-Wilcke B; Benarafa C
Microb Genom; 2020 Dec; 6(12):. PubMed ID: 33295863
[TBL] [Abstract][Full Text] [Related]
10. Microbiota bacteriana intestinal en pacientes mexicanos con inmunodeficiencia común variable.
Franco-Esquivias AP; García-De la Peña C; Torres-Lozano C; Vaca-Paniagua F; Díaz-Velásquez C; Ortega-Cisneros M; Quintero-Ramos A
Gac Med Mex; 2019; 155(5):481-486. PubMed ID: 31695233
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota in Mexican patients with common variable immunodeficiency.
Franco-Esquivias AP; Peña CG; Torres-Lozano C; Vaca-Paniagua F; Díaz-Velásquez C; Ortega-Cisneros M; Quintero-Ramos A
Gac Med Mex; 2019; 155(5):447-452. PubMed ID: 32091022
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency.
Macpherson ME; Hov JR; Ueland T; Dahl TB; Kummen M; Otterdal K; Holm K; Berge RK; Mollnes TE; Trøseid M; Halvorsen B; Aukrust P; Fevang B; Jørgensen SF
Front Immunol; 2020; 11():574500. PubMed ID: 33042155
[TBL] [Abstract][Full Text] [Related]
13. Low IgA Associated With Oropharyngeal Microbiota Changes and Lung Disease in Primary Antibody Deficiency.
Berbers RM; Mohamed Hoesein FAA; Ellerbroek PM; van Montfrans JM; Dalm VASH; van Hagen PM; Paganelli FL; Viveen MC; Rogers MRC; de Jong PA; Uh HW; Willems RJL; Leavis HL
Front Immunol; 2020; 11():1245. PubMed ID: 32636843
[TBL] [Abstract][Full Text] [Related]
14. Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma.
Lopes Dos Santos Santiago G; Brusselle G; Dauwe K; Deschaght P; Verhofstede C; Vaneechoutte D; Deschepper E; Jordens P; Joos G; Vaneechoutte M
BMC Microbiol; 2017 May; 17(1):109. PubMed ID: 28486933
[TBL] [Abstract][Full Text] [Related]
15. Unique microbial landscape in the human oropharynx during different types of acute respiratory tract infections.
Li H; Wu X; Zeng H; Chang B; Cui Y; Zhang J; Wang R; Ding T
Microbiome; 2023 Jul; 11(1):157. PubMed ID: 37482605
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions.
Varricchi G; Poto R; Ianiro G; Punziano A; Marone G; Gasbarrini A; Spadaro G
Front Immunol; 2021; 12():712915. PubMed ID: 34408753
[TBL] [Abstract][Full Text] [Related]
17. Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients.
de Steenhuijsen Piters WA; Huijskens EG; Wyllie AL; Biesbroek G; van den Bergh MR; Veenhoven RH; Wang X; Trzciński K; Bonten MJ; Rossen JW; Sanders EA; Bogaert D
ISME J; 2016 Jan; 10(1):97-108. PubMed ID: 26151645
[TBL] [Abstract][Full Text] [Related]
18. Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
Jørgensen SF; Macpherson ME; Bjørnetrø T; Holm K; Kummen M; Rashidi A; Michelsen AE; Lekva T; Halvorsen B; Trøseid M; Mollnes TE; Berge RK; Yndestad A; Ueland T; Karlsen TH; Aukrust P; Hov JR; Fevang B
Sci Rep; 2019 Jan; 9(1):167. PubMed ID: 30655568
[TBL] [Abstract][Full Text] [Related]
19. The loss of topography in the microbial communities of the upper respiratory tract in the elderly.
Whelan FJ; Verschoor CP; Stearns JC; Rossi L; Luinstra K; Loeb M; Smieja M; Johnstone J; Surette MG; Bowdish DM
Ann Am Thorac Soc; 2014 May; 11(4):513-21. PubMed ID: 24601676
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for Haemophilus influenzae and pneumococcal respiratory tract colonization in CVID.
Pulvirenti F; Camilli R; Giufrè M; Milito C; Pimentel de Araujo F; Mancini F; Cardines R; Ciervo A; Pantosti A; Cerquetti M; Quinti I
J Allergy Clin Immunol; 2018 Dec; 142(6):1999-2002.e3. PubMed ID: 30170126
[No Abstract] [Full Text] [Related]
[Next] [New Search]
